© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Curiosity about polynucleotides began to grow in the mid-20th century when biochemists pieced together the role of RNA in genetics. Sodium Polyinosinic Acid Salt (often called poly(I) sodium salt) started drawing attention during the burst of synthetic nucleic acid chemistry. Scientists made strides synthesizing homopolymers to explore how cells recognize viral RNA signatures. Back then, funding poured into basic research on immune function and innate responses to infection. It took years, and the process involved plenty of trial and error, but researchers learned how the backbone of inosinic acid could mimic natural viral signals, triggering cellular defenses in both animal models and cell cultures. This historical context built the stage for today’s wide-ranging investigations in immunology, virology, and molecular biology.
Researchers typically use sodium salts of polynucleotides because these forms dissolve easily in water-based systems. Sodium Polyinosinic Acid Salt is a polyribonucleotide made up of inosinic acid residues bound together through phosphodiester links. The sodium counterion keeps the whole molecule water-soluble and manageable under laboratory conditions. This product comes as a fine, white-to-off-white powder or sometimes as a lyophilized cake, with handling dependent on where it is needed next. Its main claim to fame among scientists has always been its ability to act as a synthetic analog for double-stranded RNA, activating toll-like receptors and unleashing an immune response for research purposes.
Sodium Polyinosinic Acid Salt stands out for its strong negative charge due to phosphate groups. It dissolves well in water, forming viscous solutions at moderate concentration ranges. Typically, solutions appear slightly cloudy, and viscosity depends mostly on molecular weight. The pH of a standard solution drifts toward the neutral-to-mildly-alkaline range, making it adaptable for cell culture scenarios. Polyinosinic strands show a handy resilience to thermal denaturation, compared to single-stranded RNA, due to their ability to self-pair or form complexes with complementary molecules like polycytidylic acid. Quality batches deliver consistent base composition with a minimized level of degradation or contamination, confirmed through optical density measurements and, in some labs, gel electrophoresis.
Bottles from leading suppliers carry detailed labeling based on batch analysis. Purity appears as a percentage, often above 95%, verified through UV absorbance at 260 nm and 280 nm. Labels mark molecular weight range, usually around 200-600 kilodaltons for standard products, sometimes going higher for special applications. RNA content shows on the label in micromoles or micrograms. Moisture content matters for some protocols, so reputable vendors print that information front and center. Many suppliers include instructions on proper storage — deep-freeze at or below -20°C — and reconstitution tips for dissolving the salt in sterile, nuclease-free water.
Production of Sodium Polyinosinic Acid Salt begins with enzymatic polymerization. Biochemists typically use polynucleotide phosphorylase to link inosinic acid nucleotides, followed by careful neutralization with sodium ions. This process allows control over polymer length by adjusting reaction time and nucleotide concentration. Deionization and desalting steps remove residual enzymes and by-products, with subsequent lyophilization to make a dry, stable final product. Quality assurance doesn’t stop at synthesis; every batch gets checked for intact polymer length, absence of nucleases, and low endotoxin levels to meet the needs of research use.
Although sodium polyinosinic acid salt acts as a polynucleotide scaffold on its own, many research groups modify it to tune its cellular recognition or stability. Chemical conjugation can attach fluorescent tags, biotin, or even polyethylene glycol (PEG) groups. These modifications help with detection, purification, or increased half-life in vivo. Enzymatic treatment with nucleases allows fragmentation into shorter pieces for comparative studies. Cross-linking with agents such as glutaraldehyde increases rigidity, which helps in experiments seeking to study structural immune recognition. Some synthetic strategies introduce modified bases for improved resistance to nucleases or altered recognition by pattern recognition receptors. These custom tweaks open up broader uses in cellular signaling and molecular diagnostics.
The world of nucleic acid chemistry generates a tangle of names. Sodium Polyinosinic Acid Salt is known in research circles as poly(I), polyinosinic acid sodium salt, sodium salt of polyinosinic acid, and polyinosine sodium salt. Each supplier might tack on catalog-specific tags or reference lot numbers for internal tracking. Some journals use abbreviations like poly(I) sodium or poly-Inosinic sodium salt in Materials and Methods sections. Knowledge of these synonyms helps researchers avoid mix-ups and choose the right product for their application.
Working with nucleic acid polymers like sodium polyinosinic acid salt takes a basic knowledge of handling biological reagents. Most research-grade material is considered non-hazardous, provided the work follows biosafety level 1 practices. Inhalation of powdered form can irritate mucous membranes, so open handling inside a fume hood remains best practice. Personnel use gloves and lab coats, not only to avoid skin contact but to prevent cross-contamination. Proper labeling and storage reduce the chance of product degradation and ensure reliable results in sensitive protocols. Waste disposal should respect institutional guidelines for chemical reagents or batch contamination, keeping lab safety a priority.
Polyinosinic acid’s most established role comes from its use as a toll-like receptor 3 (TLR3) ligand in immunology. Researchers add it to cell cultures to stimulate innate immune pathways, particularly in dendritic cells, macrophages, and fibroblasts. The response mirrors what happens during viral infection, allowing for controlled studies on cytokine production, apoptosis, and antiviral state induction. Outside immunology, molecular biologists use poly(I) to inhibit poly(A)-binding proteins or probe RNA-protein interactions. In some therapeutic development pipelines, chemically modified derivatives enter studies as potential vaccine adjuvants or anti-tumor agents. Diagnostic labs sometimes leverage the polymer as a standard for assay calibration, especially in high-sensitivity nucleic acid detection methods.
Current research with sodium polyinosinic acid salt covers a broad stretch of ground in both basic and applied science. Academic groups focus on unraveling the signaling crosstalk downstream of TLR3 engagement, hoping to find answers relevant for autoimmunity, neuroinflammation, and chronic infection. Industry investment targets formulation tweaks that might boost stability or attenuate side effects for therapeutic use. Recent grants support high-throughput screens of small molecules that modulate poly(I)-induced pathways. Nanobiotechnologists look to couple the polymer with nanoparticles for better delivery profiles, especially in cancer immunotherapy. R&D teams require robust, reproducible batches, emphasizing lot-to-lot consistency in their sourcing.
Despite its synthetic origins, sodium polyinosinic acid salt carries an immunostimulatory punch that demands respect in toxicity testing. Animal studies reveal that high doses can trigger systemic inflammation — mirroring what happens during viral attacks, but sometimes pushing the system too far. Experimenters track body temperature, cytokine profiles, and organ function after administration, especially in preclinical therapeutic research. Chronic exposure studies aim to map potential links to autoimmune activation or tissue damage. In vitro assays highlight concentration-dependent effects, with cell death or altered proliferation at excessive doses. Negative findings guide careful dose selection and risk mitigation strategies in both research and early-phase clinical development.
The landscape around sodium polyinosinic acid salt promises expansion as new discoveries shape its role in both research and medicine. Biomedical advances in innate immunity rely on reliable immune activators for both screening and translational applications. Projects focused on cancer vaccines or antiviral therapies find value in engineered polynucleotides that safely sharpen immune responses. Ongoing efforts to build smarter delivery vehicles — using liposomes, hydrogels, or nanoparticle approaches — set the stage for clinical trials. As our understanding of innate pattern recognition receptors grows, so does interest in custom-tailored analogs derived from the polyinosinic backbone. Ethical and regulatory scrutiny keeps a watchful eye on off-target effects, but the ongoing investment signals a bright, innovative future for research built on the shoulders of this robust polynucleotide.
Sodium polyinosinic acid salt stands out in labs for its ability to mimic viral genetic material. Scientists call it a “synthetic polynucleotide,” but outside of lab jargon, people recognize it as a tool that stirs up the body’s natural defenses. Think of it as a decoy—this compound tricks the immune system into thinking a virus has shown up, so cells react fast.
Researchers lean on sodium polyinosinic acid salt when studying how cells spot invading viruses. For years, I noticed immunologists reaching for this salt to wake up a specific pathway inside cells: the toll-like receptor 3 (TLR3) pathway. This pathway helps the body spot and respond to double-stranded RNA, a marker of many viruses. By using synthetic salts, scientists trigger immune reactions without bringing real pathogens into the picture.
This has poured into practical medicine. For cancer immunotherapy, research teams have added sodium polyinosinic acid salt to treatment mixes. The salt ramps up the body’s natural killer cells, turning up the heat on hidden tumors. Animal studies have shown that combining sodium polyinosinic acid salt with vaccines or cancer drugs helps immune cells catch cancer signals that would otherwise stay hidden. Some early-stage clinical trials have looked at using it as an adjuvant, hoping to make vaccines pack a stronger punch.
Drug makers use the salt as a stand-in to test new compounds in cell cultures. By setting up immune reactions with the salt, chemists see if their drug candidates stop harmful inflammation or boost protective cell responses. This lab approach gives a clearer view of how drugs interact inside living systems before they ever reach human volunteers.
With all the excitement over sodium polyinosinic acid salt, there’s a big question mark about safety in people. Faking an infection sometimes means risking overactive immune attacks. If given in the wrong setting or dose, this salt could push the body too far—fueling inflammation that damages healthy tissues. Few doctors use sodium polyinosinic acid salt directly as a medicine outside of controlled research. Strict oversight comes in, especially because the immune system’s balance is fragile. Only a handful of clinical studies have run so far; long-term effects need more clarity. Guidelines from the FDA and research ethics boards reflect those concerns, calling for detailed tracking and limited human testing.
Looking back over the last decade, signs keep pointing to a future where sodium polyinosinic acid salt helps unlock better disease-fighting strategies. Academic labs and pharmaceutical companies have formed partnerships to dig deeper into using these polynucleotide salts in drug research. With advances in gene therapy and RNA-based medicine, the salt could become a bigger player, provided strong safety records follow. Better lab models and tracking systems may hold the key to getting there. It’s a story to keep an eye on—one that brings together chemistry, immunology, and the search for better treatments on a level where real lives feel the impact.
Sodium polyinosinic acid salt comes up from time to time in discussions about antiviral drugs and vaccine research. No one grabs this chemical off a store shelf. Most often, scientists handle it in specialized labs or test it on cells in a dish. The appeal lies in its ability to mimic double-stranded RNA, which is something some viruses and the immune system recognize. By using it, researchers learn more about how our bodies recognize viral infections and ramp up defenses.
The question on people’s minds: Is it safe for human use? So far, there’s little evidence showing widespread safety data for humans. Most published studies use animal models or cell lines. For example, one classic experiment in the 1970s injected it into mice to stimulate an immune response. More recently, researchers have used versions of it in cancer models, where the idea is to alert the immune system and help it fight back against tumors.
But these studies don’t guarantee it’s okay for everyday use in humans. Animal studies give us valuable clues, but reactions can differ between a mouse and a person. In the medical world, the jump from lab to clinic involves careful steps with tight oversight at every stage.
In the limited times this compound has come near human trials, scientists have kept safety a top priority. Just about any molecule that spurs the immune system this way can cause fever, muscle aches, or more serious symptoms if used improperly. One human study from several decades ago looked at poly I:C (a compound similar to sodium polyinosinic acid salt), which led to fever and discomfort in some participants. No long-term or chronic use has ever been approved or recommended based on current records.
It’s worth mentioning that regulatory agencies such as the FDA expect strict proof of safety and effectiveness before approving anything new for medical use. Sodium polyinosinic acid salt hasn’t made its way through that door. No prescription exists, and you won’t find it in any over-the-counter product. Anyone promising benefits beyond established science sets off major alarm bells for healthcare professionals.
Science moves forward with careful steps. More high-quality studies in humans would help clarify if sodium polyinosinic acid salt could someday play a role beyond research labs. Academic and industry collaboration would speed up any clinical trials, each checked for possible side effects like immune overactivation or allergy. Open data sharing between research teams makes it easier to spot patterns early, catching problems before they grow.
But, for now, trusting medical advice from licensed professionals and looking for treatments with clear regulatory approval keeps people safe. No shortcut replaces the safety checks designed to protect everyone. For those curious about new treatments, transparency and scientific consensus carry the most weight. Until more evidence comes in, the best answer stays clear: let science keep studying, but approach with extra caution for anything not examined fully in human volunteers.
Sodium polyinosinic acid salt might shape research behind the scenes, but questions about its safety for human use still stand. Proper protections in clinical testing serve not just scientists but everyone hoping for better health outcomes. With time, science may reveal new uses, but making health choices stands strongest on careful evidence, not just laboratory hope.
Sodium Polyinosinic Acid Salt often plays a crucial part in research, especially in immunology labs hunting for new ways to treat disease or understand immune response. Years ago, I watched a lab lose half a batch of an expensive reagent because someone tossed it in a warm closet instead of the cold room. That mistake slowed everything down for weeks. Nobody wants a repeat of that kind of headache. So it pays to get storage right.
The powder holds up best when stored at temperatures between two and eight degrees Celsius. Most standard laboratory refrigerators do the trick; there’s no special gear involved, just diligence. Storing it cold slows down the natural process of breakdown. Leaving it at room temperature accelerates degradation, even if the bottle looks fine on the outside.
Humidity can sneak into the bottle and start messing with the salt’s properties. A desiccator helps draw excess moisture from the air, keeping unwanted clumping or chemical changes at bay. I’ve personally seen white powders turn sticky just by being left out too long in a humid room. Place it tight inside a sealed container with a fresh desiccant, and the salt stays usable longer.
Leaving the bottle out on a bench under lab lights seems harmless, but UV breaks down molecules over time. That drop in quality leads to inconsistent results nobody wants in published data. Opaque or amber storage bottles add a layer of protection. If a sample must be stored at the bench, wrapping the container in foil helps, too.
There’s a reason manufacturers spend money on specialized bottles and seals. Moving the powder into another vessel risks contamination. Even small dust particles can impact purity. I’ve seen researchers switch to glass vials, then wonder why the next experiment flopped—the culprit was micro-contaminants from the switch. Stick with the original bottle until the last grain is used.
Labs get busy, schedules fill up, and suddenly bottles without dates crowd the fridge. Clear, accurate labeling with open date and contents saves confusion. Tossing out a $400 reagent because nobody knows how long it’s been open is painful. Keeping an inventory log on paper or a simple spreadsheet helps spot problems early and avoid expired material sneaking into experiments.
Ready access to cold, dry, protected, and well-labeled storage areas makes all the difference in product quality. Groups can set up simple reminders for checks, refresh desiccants regularly, and review inventory a few times a month. All these steps make experiments more reliable and budgets last longer.
Lab staff look after sodium polyinosinic acid salt like it’s precious gold dust. Each element—from keeping it cool to tracking use—adds up to stronger research and fewer setbacks. Getting storage right lets the science speak for itself, not the state of the bottle it came from.
Most researchers I know have learned the hard way that cutting corners on protocol can derail good science. Sodium Polyinosinic Acid Salt looks like just another chemical on the shelf, but the amount used in research experiments changes everything: cell viability, response profiles, and project outcomes can all shift, often dramatically, because of one wrong pipette move.
It’s tempting to hunt for a magic number — the “standard” concentration that always works. But scientific journals tell a different story. Dosage for sodium polyinosinic acid salt tends to land between 1 μg/mL and 100 μg/mL, and settling on a number depends on the cell line, endpoint assay, and research question. Early immunology studies often lean on 10 μg/mL as a middle ground for lymphocyte stimulation, but some cell types barely flinch at that dose, others might go into overdrive, and a few just die off.
We all want clean, reproducible data. Data on the wrong dose tells a false story — a fact that veteran scientists drive home by sharing cautionary tales from failed pilot experiments. In my own work, pushing past 50 μg/mL triggered off-target effects that looked like magic in the data, until control runs clarified that I’d just been too heavy-handed.
Too little sodium polyinosinic acid salt leaves immune cells indifferent. They float through the test weeks, wasting time and funding. Excessive levels cause cell death or immune overactivation, neither of which mirrors in vivo performance. Published research even shows high concentrations can cloud endpoint assays, making fluorescence readings or protein analyses unreliable.
Dilution series can sort out optimal dosage, yet researchers often underestimate the value of taking the time for gradients. Getting it right isn’t just about saving supplies. It ripples through budgets, timelines, and even grad students’ morale.
Reading the manufacturer’s recommendations forms the baseline, though real-world experience often takes precedence. Reagents degrade under bad storage, so even the freshest bottle should be tested before serious experiments start. Some labs, after seeing person-to-person technique variability, keep detailed logbooks of batch numbers, concentrations, and outcomes.
Always, quality research includes dose-finding experiments for new applications. That small investment at the front end pays off. One colleague’s team standardized their protocol after running a 2 μg/mL to 100 μg/mL ladder, picking 10 μg/mL as the sweet spot for T cell assays based on viability and cytokine secretion numbers. Their turnover improved, and their publications gained traction as a result.
Strong research groups learn from mistakes by sharing both successes and missteps. Setting aside time for pilot dose-response experiments unburdens main projects downstream and increases reproducibility. Keeping a community mindset — sharing methods and lessons with other labs — helps everyone avoid pitfalls. For labs starting out with sodium polyinosinic acid salt, the best dose starts on the low end with methodical increases and constant documentation. No matter the temperament of the science, respecting the chemistry pays off in reliable, honest work that builds trust across disciplines.
Labs and manufacturers come across Sodium Polyinosinic Acid Salt frequently, often as a reagent or research tool. Purity affects how predictable your outcomes are. Anything less than high purity introduces doubt at every step—one batch could be reliable, the next might skew results. Most commercially available Sodium Polyinosinic Acid Salt claims purity above 95%. Lab tests often confirm this, though you may see product variability if quality control slips. Even a small change can be enough to affect cell culture work, molecular biology assays, or immune activation studies. If the solution is cloudy or shows unexpected precipitation, purity probably falls short and may contain nucleic acid fragments, unwanted salts, or microbial contamination.
Years working with research groups tell me a clear story: underestimated impurity leads to unnecessary troubleshooting and sometimes wasted months. For clinical research or immunological assays, “good enough” purity wastes resources. Reputable suppliers routinely run HPLC or gel electrophoresis to show their purity claims. Always demand a Certificate of Analysis, and double-check if your application requires RNase-free or endotoxin-free grades. Anyone testing gene editing, RNA interference, or nucleic acid immunostimulation pays for it later if the initial material is off.
Unlike small molecules with fixed values, the molecular weight of Sodium Polyinosinic Acid Salt isn’t a single number. This compound exists as a polynucleotide—a long string of inosinic acid units. Chain length can shift depending on synthesis or extraction technique. Most vendors will specify an average molecular weight, often ranging between 60,000 and 700,000 Daltons. I’ve worked with both ends of that spectrum, and the difference shows. Higher molecular weight enhances the ability to form stable complexes and can boost the induction of immune response, because longer chains present more surface area for recognition by cellular receptors.
Molecular weight matters a lot for consistency. Shorter chains might be easier to dissolve and handle, but may not trigger the desired biological effect. For anyone in vaccine research or immunological modeling, choosing the correct profile saves time and money. Gel electrophoresis gives a decent estimate, but size exclusion chromatography provides a more precise distribution curve. Suppliers who conduct rigorous fractionation help keep experiments on track. It's a small detail, but confirming average chain length before starting saves headaches in translation and scale-up.
It pays to request detailed characterization with each batch purchase. Don’t settle for a generic datasheet—ask for clear documentation showing both purity and molecular weight distribution. Labs running repeated protocols should consider batch reservation or even in-house verification. Buying from suppliers certified for GMP or ISO standards reduces risk.
If your protocols break down or results drift, purity and molecular weight should be among the first factors checked. Applying regular QC—think UV absorbance for concentration and contaminant checks, along with periodic HPLC or PAGE analysis—avoids plenty of problems later. Building a relationship with a trusted supplier who understands your field provides continuous support.
Sticking to a high standard is worth it. Research, especially involving nucleic acids, demands consistency and transparency. In the end, those who track both purity and molecular weight get projects delivered on time and stand behind their data with confidence.
| Names | |
| Preferred IUPAC name | sodium poly[(1→6)-β-D-inosine-5′-ylate] |
| Other names |
Polyinosinic acid sodium salt Polyinosine sodium salt Poly(I) sodium salt |
| Pronunciation | /ˌsoʊdiəm ˌpɒliˌaɪnoʊˈsɪnɪk ˈæsɪd sɔlt/ |
| Identifiers | |
| CAS Number | 53572-82-6 |
| Beilstein Reference | 3569785 |
| ChEBI | CHEBI:91180 |
| ChEMBL | CHEMBL1208408 |
| ChemSpider | 21598011 |
| DrugBank | DB15640 |
| ECHA InfoCard | 03e22024-974b-4409-8c18-3bbd4bea0c56 |
| EC Number | 232-071-7 |
| Gmelin Reference | 86922 |
| KEGG | C00607 |
| MeSH | D050197 |
| PubChem CID | 25250629 |
| RTECS number | NL6476000 |
| UNII | F75008Y4OT |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID9024267 |
| Properties | |
| Chemical formula | (C10H11N4NaO7P)n |
| Molar mass | 928.6 g/mol |
| Appearance | White to off-white powder |
| Odor | Odorless |
| Density | Density: 1.87 g/cm³ |
| Solubility in water | soluble in water |
| log P | -8.7 |
| Magnetic susceptibility (χ) | -9.9e-6 cm³/mol |
| Viscosity | Viscous solution |
| Pharmacology | |
| ATC code | J05AX |
| Hazards | |
| Main hazards | May cause respiratory and eye irritation. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | No hazard statements. |
| Precautionary statements | Precautionary statements: P261, P305+P351+P338 |
| NFPA 704 (fire diamond) | 2-1-0 |
| LD50 (median dose) | LD50 (median dose): >5 g/kg (rat, oral) |
| PEL (Permissible) | Not established |
| REL (Recommended) | 20 mg/ml |
| Related compounds | |
| Related compounds |
Polycytidylic acid Polyinosinic:polycytidylic acid Polyadenylic acid Polyuridylic acid |
